Impersonalized medicine.

Area of Science:

• Oncology
• Metabolic pathways
• Cancer therapy

Background:

• Cancer cells exhibit altered metabolic pathways compared to normal cells.
• Chemotherapeutic drugs can cause significant toxicity to both cancerous and healthy cells.
• Understanding cellular stress responses is crucial for improving cancer treatment efficacy.

Purpose of the Study:

• To investigate the therapeutic benefits of short-term food withdrawal (fasting) in cancer treatment.
• To explore how fasting affects the differential response of tumor cells versus normal cells to chemotherapy.
• To determine if fasting can enhance the efficacy and reduce the toxicity of cancer therapies.

Main Methods:

• Implementing short-term fasting protocols in preclinical cancer models.
• Administering standard chemotherapeutic agents during fasting periods.
• Analyzing the impact of fasting on tumor cell viability and normal cell function.
• Assessing cellular stress responses at a molecular level.

Main Results:

• Fasting significantly weakened the survival of tumor cells when exposed to chemotherapy.
• Normal cell function and resilience were enhanced during fasting periods.
• The differential stress response created by fasting improved the therapeutic index of chemotherapy.
• Key molecular pathways involved in stress resistance were modulated by fasting.

Conclusions:

• Short-term fasting is a promising complementary strategy for cancer therapy.
• Fasting enhances chemotherapy effectiveness by selectively targeting cancer cells.
• This approach offers a potential method to improve treatment outcomes and reduce side effects in cancer patients.